“In the pharmaceutical sector I think Italy could do better in accessing innovation in terms of speed. Our new therapeutic solutions, all the efforts and all the thousands of people who work to bring innovation to Italy, are null and void, they are useless if these therapies do not reach the patient. So the speed of access to innovation is very important.” This was stated by Peter Guenter, CEO Healthcare of Merck Group, during a meeting with the press at the Merck plant in Guidonia (Rome).
#Guenter #Merck #Italy #speed #access #innovative #therapies
